GLPG3970
Modify Date: 2024-01-03 21:32:42
GLPG3970 structure
|
Common Name | GLPG3970 | ||
|---|---|---|---|---|
| CAS Number | 2403733-82-2 | Molecular Weight | 504.50 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H27F3N4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GLPG3970GLPG3970 (compound 88) is a first-in-class SIK2/SIK3 inhibitor. GLPG3970 can be used for the research of inflammation and autoimmune disease[1]. |
| Name | GLPG3970 |
|---|
| Description | GLPG3970 (compound 88) is a first-in-class SIK2/SIK3 inhibitor. GLPG3970 can be used for the research of inflammation and autoimmune disease[1]. |
|---|---|
| Related Catalog | |
| In Vivo | GLPG3970 (10 mg/kg；口服，每日两次，连续五天) 在皮内注射 IL-23 诱导的银屑病表皮增生小鼠模型中降低耳厚[1]。 GLPG3970 (60 mg/kg；口服， 每日两次，直到老鼠被杀) 在小鼠胶原抗体诱导关节炎模型 (CAIA) 中，有良好的临床表现[1]。 GLPG3970 (10 mg/kg；口服， 每日两次，连续七天) 在小鼠 T 细胞转移模型中，与对照组相比降低疾病活动指数[1]。 |
| References |
| Molecular Formula | C25H27F3N4O4 |
|---|---|
| Molecular Weight | 504.50 |